Thymosin alpha-1, also called thymalfasin or TA-1, is an immune-modulating peptide studied for infections, hepatitis, cancer support, sepsis, and immune dysfunction 1, 2. It is not a routine FDA-approved U.S. drug product based on current Drugs@FDA checks, and patients should not use “research use only” peptides for self-treatment 6. In the U.S., access, prescription, and compounding rules are complex and should be checked with a licensed clinician and current FDA guidance.
Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you buy thymosin alpha-1 peptide online?
You may see thymosin alpha-1 sold online, but a listing is not the same as a medication that is appropriate for human use. The key issue is whether the product is prescribed after clinician review and dispensed through a lawful medication channel, not whether a website can ship a vial.
Why online TA-1 listings can be confusing
Online pages may use names like thymosin alpha-1, TA-1, thymalfasin, or Zadaxin. They may also show lab-style purity claims, powder photos, or research labels. Those details can make a product look medical, even when the seller says it is not for human use.
The difference between research-use products and medication for human use
A research-use-only peptide is intended for laboratory work, not for a person to inject or ingest. A medication for human use should involve a licensed clinician, appropriate patient screening, a lawful pharmacy pathway when prescribed, sterility controls, adverse-event support, and clear labeling 3, 4.
Why a low price or purity claim is not enough
A low price does not confirm identity, sterility, potency, or safe handling. A “99% purity” claim also does not tell you whether the product was made, stored, labeled, and shipped as medication for human use. FDA online-pharmacy guidance warns patients to be cautious with websites that sell prescription-type products without proper oversight 5.
What is thymosin alpha-1?
Thymosin alpha-1 is a synthetic thymic peptide and immune-modulating peptide 1, 2. In plain English, it is a short chain of amino acids modeled on immune signals linked to the thymus, an organ that helps train immune cells 1.
How TA-1 relates to the thymus and immune signaling
The thymus helps T cells mature and learn how to respond to threats. Reviews describe thymosin alpha-1 as interacting with immune pathways that include T cells, dendritic cells, natural killer cells, cytokine signaling, Toll-like receptor signaling, and downstream MyD88/NF-κB activity 1, 2.
What thymalfasin means
Thymalfasin is another name used for synthetic thymosin alpha-1. Many clinical papers use thymalfasin when they discuss pharmaceutical TA-1 products studied in humans 1.
What Zadaxin is and where it has been discussed in research
Zadaxin is a branded thymalfasin product discussed in the medical literature and in international settings. Brand discussion does not mean the product is FDA-approved or available as a routine U.S. prescription product; U.S. approval status should be checked in current FDA drug databases 6.
Does thymosin alpha-1 really work?
The honest answer is condition-specific. TA-1 has been studied in humans for several immune-related diseases, but that evidence should not be stretched into claims that it improves longevity, energy, fatigue, or general wellness.
What human studies and reviews have investigated
Human research has evaluated thymosin alpha-1 or thymalfasin in chronic hepatitis B, chronic hepatitis C, sepsis, viral infections, malignancy-related immune support, and vaccine-response settings 1, 2. A registered clinical trial also studied thymalfasin in COVID-19, which shows research interest but does not prove routine benefit for self-treatment 7.
Where evidence is stronger
Reviews describe more developed human evidence in hepatitis and some immune-related clinical settings than in wellness use 1, 2. Even there, study results depend on the disease, background treatment, route, dose used in the study, product quality, and patient risk.
Where evidence is still uncertain
For general immunity, longevity, fatigue, “immune optimization,” and broad wellness claims, the evidence is much less certain. A mechanism in T cells or cytokine signaling is not the same as a proven patient outcome, and individual results vary.
Side effects, contraindications, and why benefits cannot be promised
Published reviews describe thymosin alpha-1 as generally well tolerated in studied populations, but safety depends on the patient and the product 1, 2. Possible concerns include injection-site reactions, immune-related symptoms, allergy risk, unknown interactions, and extra caution for people with autoimmune disease, transplant history, cancer treatment, pregnancy, or complex immune conditions.
Do you need a prescription for thymosin alpha-1?
For human therapeutic use, thymosin alpha-1 should not be treated like a supplement or lab supply. Any peptide used as medication should involve a licensed clinician who can assess eligibility, risks, and follow-up needs.
Why therapeutic use should involve a licensed clinician
A clinician review matters because immune-modulating products can be a poor fit for some people. A provider can look for contraindications, drug interactions, immune disorders, infection risk, pregnancy status, cancer treatment issues, and signs that symptoms need standard medical care rather than a peptide.
How U.S. FDA approval status differs from international availability
A product may be discussed in other countries or in clinical studies without being an FDA-approved drug in the United States. Drugs@FDA is the official FDA database for approved drug products, and it is the right starting point for checking whether a named product has U.S. approval 6.
Why compounded peptide availability can change
U.S. compounding law is not the same as supplement law. FDA explains that section 503A applies to patient-specific prescriptions from licensed practitioners and that bulk drug substances must meet specific legal requirements 3. Because peptide policy can change, current FDA and state pharmacy guidance matters.
Questions to ask a clinic before considering any peptide treatment
- Is this product FDA-approved, compounded, or research-use-only?
- If compounded, what state-licensed pharmacy dispenses it?
- What human evidence supports this use, and what are the limits?
- What side effects, interactions, and contraindications apply to me?
- How do I contact the care team if I have a reaction?
What are the risks of buying thymosin alpha-1 online?
The main risk is not just whether the peptide “works.” The bigger risk is using research-use-only material as if it were a human medication.
Research-use-only labeling and why it matters
If a label says research-use-only, not for human consumption, or not for therapeutic use, take that literally. Those phrases mean the product is not being offered as a medication for a patient.
Sterility, contamination, identity, and dosing risks
Peptides sold online may be mislabeled, contaminated, degraded, or different from what the buyer expects. Sterility is especially important for injections because unsafe injection practices can lead to serious infections and other harms 4.
Risks of self-injection without medical oversight
Self-injection adds risks from wrong technique, wrong route, infection, allergic reaction, and lack of follow-up. CDC injection-safety guidance stresses aseptic technique and safe handling because contamination can harm patients 4.
Red flags to avoid
- No licensed clinician review before shipment
- No pharmacy name, license information, or prescription process
- Claims that TA-1 cures, prevents, or guarantees protection from disease
- A seller telling you to ignore research-use-only labeling
- No plan for side effects, lab monitoring, or adverse-event reporting
FDA’s BeSafeRx program warns that unsafe online pharmacies may sell products without proper safeguards, and FDA’s MedWatch program is one route for reporting serious problems with medical products 5, 8.
How does thymosin alpha-1 compare with other longevity peptides?
Thymosin alpha-1 is mainly discussed as an immune-modulating peptide. It should not be treated as interchangeable with sermorelin, GHK-Cu, NAD+, or glutathione, which have different targets and safety questions.
| Option | What it is | Main patient-facing research area | Chia availability |
|---|---|---|---|
| Thymosin alpha-1 / TA-1 / thymalfasin | Synthetic thymic peptide and immune modulator 1, 2 | Studied in hepatitis, infections, sepsis, cancer adjunctive care, and vaccine response 1, 2 | Not currently offered by Chia |
| Sermorelin | Growth-hormone-releasing hormone analog 9 | Used in clinician-guided longevity and body-composition discussions; evidence and risks are different from TA-1 9 | Chia offers injections, nasal spray, and tablets; injection and nasal spray plans currently start at $179/mo |
| GHK-Cu | Copper peptide used in skin-focused care 10 | Skin appearance and repair biology; not an immune substitute for TA-1 10 | Chia offers cream; plans currently start at $159/mo |
| NAD+ | Cellular cofactor involved in energy metabolism 11 | Metabolic and cellular-health research; not a thymic peptide 11 | Chia offers injections from $179/mo and nasal spray from $119/mo |
| Glutathione | Antioxidant molecule made in the body 12 | Oxidative-stress biology; not interchangeable with immune-modulating TA-1 12 | Chia offers injections and nasal spray; plans currently start at $179/mo |
Some patients ask about multi-treatment longevity care rather than one peptide. At Chia, the Foundation Longevity protocol includes Sermorelin Injection, NAD+ Injection, and Glutathione Injection; it does not include thymosin alpha-1. Plans currently start at $399/mo, and a prescription requires clinical review and is not guaranteed.
Does Chia offer thymosin alpha-1 online?
No. Chia does not currently offer thymosin alpha-1, thymalfasin, or Zadaxin. We can still help patients understand safer access principles and consider treatments that are actually in our current catalog, when clinically appropriate.
Chia’s clinician-reviewed online process for treatments it does offer
For treatments Chia offers, the process is 100% online: you complete a health questionnaire, then a licensed U.S. provider reviews it. If treatment is clinically appropriate, the medication is compounded by a state-licensed 503A pharmacy and shipped to your door. A prescription is never guaranteed.
Current Chia longevity-related options
Chia’s current longevity-related options include Sermorelin, NAD+, Glutathione, and GHK-Cu, as well as selected protocols. These are different treatments with different mechanisms, evidence limits, side effects, and eligibility rules.
How to start if you want to discuss available Chia treatments
If you want to talk with Chia about treatments we do offer, you can start with the eligibility quiz. The quiz does not approve treatment by itself; it begins the clinical review process.
What should you ask before starting any peptide therapy?
Before any peptide therapy, ask practical safety questions. The goal is to confirm clinician oversight, lawful dispensing, human evidence, and a clear plan if side effects happen.
- 1Is this medication FDA-approved, compounded, or research-use-only?
- 2If compounded, is the pharmacy state-licensed and operating under the right legal pathway?
- 3What human evidence supports this use, and what evidence is missing?
- 4What side effects, contraindications, interactions, and monitoring apply?
- 5Who do I contact if I have an adverse reaction, and when should I seek urgent care?
This is especially important for immune-modulating peptides. Symptoms like recurrent infections, severe fatigue, fever, weight loss, or swollen lymph nodes deserve a standard medical evaluation, not self-treatment with a product from an online research supplier.
Thymosin alpha-1 is also called TA-1 or thymalfasin. Zadaxin is a branded thymalfasin product discussed in international medical literature.
Yes. Thymalfasin is the pharmaceutical name often used for synthetic thymosin alpha-1 in clinical studies and product discussions.
Zadaxin is discussed in international literature, but U.S. availability and approval status should be checked through current FDA resources. Do not assume a product is legally available in the U.S. because it is used or studied elsewhere.
You may see TA-1 sold online, but products labeled research-use-only or not for human consumption should not be used for self-treatment. Therapeutic peptide use should involve a licensed clinician.
No. Research-grade thymosin alpha-1 is not intended for personal injection, ingestion, or treatment. It may not meet medication standards for sterility, labeling, potency, storage, or patient safety.
It is often marketed that way, but the stronger human research has focused on immune-related medical settings, not proven life-extension or general wellness outcomes.
No. Chia does not currently offer thymosin alpha-1, thymalfasin, or Zadaxin. Chia does offer other clinician-reviewed longevity-related treatments, including sermorelin, NAD+, glutathione, and GHK-Cu, when appropriate after medical evaluation. Compounded medications are not FDA-approved.
References
- 1.King R, Tuthill C. Thymosin alpha 1: A comprehensive review of the literature. World Journal of Virology. 2020.
- 2.Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1. PubMed-indexed review. 2024.
- 3.U.S. Food and Drug Administration. Human Drug Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act. FDA. 2026.
- 4.Centers for Disease Control and Prevention. Injection Safety: Information for Providers. CDC. 2024.
- 5.U.S. Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information. FDA. 2024.
- 6.U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs. FDA. 2026.
- 7.ClinicalTrials.gov. Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection, NCT04487444. National Library of Medicine. 2020.
- 8.U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. FDA. 2026.
- 9.DailyMed. Sermorelin acetate injection labeling. National Library of Medicine. 2024.
- 10.Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018.
- 11.Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021.
- 12.Minich DM, Brown BI. A review of dietary, supplemental, and endogenous sources of glutathione. Nutrients. 2019.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
